Mfn Partners Management, LP Ironwood Pharmaceuticals Inc Transaction History

Mfn Partners Management, LP

  • $3.18 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$9.14 - $11.97 $30.8 Million - $40.3 Million
-3,370,000 Closed
0 $0
Q1 2020

May 14, 2020
SELL
$8.58 - $14.01 $26.3 Million - $43 Million
-3,069,541 Reduced 47.67%
3,370,000 $34 Million
Q3 2019

Nov 14, 2019
BUY
$8.59 - $10.96 $12.9 Million - $16.4 Million
1,500,000 Added 30.37%
6,439,541 $55.3 Million
Q4 2018

Feb 14, 2019
BUY
$7.8 - $16.13 $38.5 Million - $79.7 Million
4,939,541 New
4,939,541 $51.2 Million

Others Institutions Holding IRWD

# of Institutions
296
Shares Held
170M
Call Options Held
27.1M
Put Options Held
2.28M
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $999M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Mfn Partners Management, LP Portfolio

Follow Mfn Partners Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mfn Partners Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mfn Partners Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email